MidCap Provides New $31MM Facility to AxoGen
AxoGen completed the refinancing of its existing debt agreement with a new $31 million facility from MidCap Financial.
AxoGen completed the refinancing of its existing debt agreement with a new $31 million facility from MidCap Financial.
MidCap Financial hired James Garlick as director of originations for the Asset-Based Lending group.
MidCap Financial closed a $25 million senior credit facility with network and infrastructure service provider Goodman Networks.
Oxford Immunotec Global entered into an agreement with MidCap Financial that provides the company with $40 million in debt financing, comprised of a term loan and a revolving line of credit.
BioCryst Pharmaceuticals closed a $23 million senior credit facility with Midcap Financial.
MidCap Financial and Silicon Valley Bank expanded a term loan and revolving line of credit to $20 million for Vericel.
MidCap Financial provided a new $56.5 million secured term loan credit facility with OHA Investment.
Aptevo Therapeutics, a biotechnology company focused on developing oncology and hematology therapeutics, has closed on a $35 million term loan agreement with MidCap Financial.
IOU Financial entered into a $50 million credit facility with MidCap Financial with an initial commitment of $25 million that can be expandable to $50 million at IOU’s request and the lender’s acceptance.
Spectra7 Microsystems closed a $6.5 million senior secured term loan facility with Midcap Financial and certain lenders.